Clinical Trial Update: A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for 6MW3211 injection in advanced malignant neoplasm is in Phase 1 and Phase 2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• 6MW3211

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Advanced Malignant Neoplasm | Phase 1, Phase 2 | Status: UNKNOWN